Clinical trials and the age of blood: ABLE but still wanting.
about
Omics markers of the red cell storage lesion and metabolic linkage.Use of n-of-1 (single patient) trials to assess the effect of age of transfused blood on health-related quality of life in transfusion-dependent patients.Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells.Expanding access to Transfusion Medicine and improving practice: guidelines, patient blood management, protocols and products.A trial is a trial is a trial: the need for an evidence-based clinical approach for evaluation of stored red cell.
P2860
Clinical trials and the age of blood: ABLE but still wanting.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Clinical trials and the age of blood: ABLE but still wanting.
@en
Clinical trials and the age of blood: ABLE but still wanting.
@nl
type
label
Clinical trials and the age of blood: ABLE but still wanting.
@en
Clinical trials and the age of blood: ABLE but still wanting.
@nl
prefLabel
Clinical trials and the age of blood: ABLE but still wanting.
@en
Clinical trials and the age of blood: ABLE but still wanting.
@nl
P2093
P2860
P356
P1433
P1476
Clinical trials and the age of blood: ABLE but still wanting.
@en
P2093
B H Chin-Yee
I H Chin-Yee
P2860
P304
P356
10.1111/TME.12252
P577
2015-09-25T00:00:00Z